Addus HomeCare Co. (NASDAQ:ADUS) Receives Average Recommendation of “Buy” from Analysts

Addus HomeCare Co. (NASDAQ:ADUS) has received an average recommendation of “Buy” from the ten research firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $132.78.

Several analysts have weighed in on the company. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. JMP Securities began coverage on Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective on the stock. Oppenheimer upped their price objective on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Stephens restated an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th.

Addus HomeCare Price Performance

Shares of ADUS stock opened at $89.83 on Monday. The business’s fifty day moving average price is $111.83 and its 200 day moving average price is $121.75. Addus HomeCare has a 1-year low of $87.88 and a 1-year high of $136.72. The firm has a market capitalization of $1.63 billion, a PE ratio of 20.56, a P/E/G ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Equities research analysts expect that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares in the company, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Addus HomeCare

Large investors have recently modified their holdings of the company. Quarry LP purchased a new position in shares of Addus HomeCare in the 3rd quarter worth about $28,000. Natixis raised its holdings in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company’s stock worth $31,000 after purchasing an additional 132 shares during the period. Smartleaf Asset Management LLC raised its holdings in shares of Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock worth $35,000 after purchasing an additional 214 shares during the period. Parkside Financial Bank & Trust raised its holdings in shares of Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after purchasing an additional 148 shares during the period. Finally, Meeder Asset Management Inc. purchased a new position in shares of Addus HomeCare in the 4th quarter worth about $77,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.